55 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
24 Aug 23
Report of Foreign Private Issuer
7:19am
patients in the European Union
Another gene therapy resulting from Telethon research made available is the one for a serious neurodegenerative
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
28 Dec 22
Report of Foreign Private Issuer
7:07am
: Hilton San Francisco Union Square
For more information to request a meeting please register here
BIO CEO & Investor Conference – New York, Motti
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
16 May 22
Can-Fite Granted Key NASH Patent in Israel
7:09am
in approximately 40 countries and territories including Japan, South Korea, Hong Kong, Mexico, and in the European Union. It addresses the use
6-K
EX-10.1
vr47emwv
16 Aug 21
Report of Foreign Private Issuer
10:21am
6-K
EX-10.1
qfz7tz1
8 Jul 20
Report of Foreign Private Issuer
10:39am
6-K
EX-10.1
6cs27t9bpff
12 Jun 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
06wo1p05x65de0r
4 Jun 20
Report of Foreign Private Issuer
7:21am
6-K
EX-10.1
x7hsk003gw63n
12 Feb 20
Report of Foreign Private Issuer
4:31pm
424B4
cemf6 zt9m
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
hdcn 4no9i2ls9s9ur
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1/A
EX-10.32
cxzpir
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
3m4oxu vsb
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.2
1b6mth81jouzql
30 Aug 19
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
3zkmo6ymffg7ujyxswj
22 May 19
Report of Foreign Private Issuer
9:17am
6-K
EX-10.1
we0zljz w470pgzzh
4 Apr 19
Report of Foreign Private Issuer
9:17am